Efficacy of Antistax® in Improving Microcirculation of the Skin in the Leg in Patients Suffering From Chronic Venous Insufficiency
NCT02191163 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 71
Last updated 2014-07-16
Summary
Study to determine the efficacy and safety of Antistax® film coated tablets in improving microcirculation of the skin in the leg of patients with chronic venous insufficiency (CVI)
Conditions
- Venous Insufficiency
Interventions
- DRUG
-
Antistax®
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-04-30
- Primary Completion
- 2002-08-31
More Related Trials
-
Comparative Efficacy of Two Preparations of the Association Diosmin (450 mg) + Hesperidin (50 mg) in the Treatment of Chronic Venous Insufficiency (CVI)
NCT01110512 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
NCT03006770 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions
NCT00566657 ·Status: COMPLETED ·Phase: PHASE3
-
Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease
NCT00797056 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of a Dietary Supplement Composed of Diosmin, Hesperidin, Bromelain, and Ruscus Aculeatus on the Quality of Life in Subjects With Lower Limb Disorders Possibly Prodromal to Chronic Venous Disease
NCT07185386 ·Status: COMPLETED ·Phase: NA
-
Comparative Pharmacokinetic Study Between Two Extended-Release Cilostazol Formulations in Korea
NCT03524963 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease
NCT00113009 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 Administered Alone or With Dabigatran Etexilate
NCT01688830 ·Status: COMPLETED ·Phase: PHASE1
-
EXPLORATORY ASSESSMENT OF THE EFFECTS OF CYCLO 3 ® FORT (Ruscus Extract, Hesperidin Methyl Chalcone, Ascorbic Acid) OR MICRONISED PURIFIED FLAVONOID FRACTION ON VASCULAR PARAMETERS AND BIOMARKERS IN WOMEN SUFFERING FROM CHRONIC VENOUS DISEASE (CEAP C2 OR C3), OVER 8 WEEKS
NCT02907320 ·Status: WITHDRAWN ·Phase: PHASE2
-
BEETroot Juice to Reverse Functional Impairment in PAD
NCT05624125 ·Status: RECRUITING ·Phase: NA
-
Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)
NCT01952756 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)
NCT01679990 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Tolerability Study of RJX Drug Product in Healthy Participants
NCT03680105 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of VLTS-589 in Subjects With Intermittent Claudication
NCT00068133 ·Status: COMPLETED ·Phase: PHASE2
-
Pentoxifylline and Lumbar Radiculopathy
NCT03060434 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes
NCT05205005 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Bioflavanoids on Vascular Wall Remodeling in Patients With Varicose Veins
NCT06367166 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow and Exercise Capacity in Patients With Peripheral Artery Disease
NCT03493412 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran
NCT01955720 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
NCT00059657 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
NCT01131013 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Oral Inorganic Nitrate Supplementation on Lower Limb Perfusion During Exercise in Patients With PAD
NCT05036213 ·Status: RECRUITING ·Phase: PHASE1
-
Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication
NCT00725881 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins
NCT00377806 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of DKB-119 in Patients in Crow's Feet
NCT06021418 ·Status: UNKNOWN ·Phase: NA